ORGANOGENESIS HOLDINGS INC. Increase (Decrease) in Prepaid Expense
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Increase (Decrease) in Prepaid Expense of -$146.25 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2018-11-09
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense for the quarter ending 2018-09-30 was -$73.75K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense for the quarter ending 2018-06-30 was -$73.75K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense for the quarter ending 2018-03-31 was $1.25K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense for the quarter ending 2017-12-31 was -$73.75K.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense for fiscal 2017 was -$227.29K, a 157.42% decline from fiscal 2016.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense for fiscal 2016 was $395.84K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$73.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$147.50K derived: sum of 2 quarters · filed 2018-11-09 | -$146.25K 10-Q · filed 2018-11-09 | -$220.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | -$73.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$72.50K 10-Q · filed 2018-08-07 | -$146.25K derived: sum of 3 quarters · filed 2018-08-07 | -$220.41K derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-03-31 | $1.25K 10-Q · filed 2018-05-10 | -$72.50K derived: sum of 2 quarters · filed 2018-05-10 | -$146.66K derived: sum of 3 quarters · filed 2018-11-09 | -$223.72K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-12-31 | -$73.75K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$147.91K derived: sum of 2 quarters · filed 2018-11-09 | -$224.97K derived: sum of 3 quarters · filed 2018-11-09 | -$227.29K 10-K · filed 2018-03-14 |
| 2017-09-30 | -$74.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$151.22K derived: sum of 2 quarters · filed 2018-11-09 | -$153.54K 10-Q · filed 2018-11-09 | |
| 2017-06-30 | -$77.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$79.38K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$2.32K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $395.84K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |